SeaStar Medical Restores Executive Salaries and Board Retainers After Cost-Cutting Measures
Reuters
Sep 30
SeaStar Medical Restores Executive Salaries and Board Retainers After Cost-Cutting Measures
**SeaStar Medical Holding Corporation Announces Restoration of Executive and Director Compensation** SeaStar Medical Holding Corporation has announced changes to its executive and board compensation structure. Effective October 1, 2025, the annual base salaries for CEO Eric Schlorff, Chief Medical Officer Kevin Chung, and select management team members will increase, restoring their compensation to previous levels before a 20% reduction implemented in June 2025. The company will also reinstate directors' cash retainer fees and additional board compensation to original amounts, reversing cuts made as part of earlier cost-saving measures. SeaStar Medical expects these adjustments to raise its monthly operating expenses by approximately $50,000.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seastar Medical Holding Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-030023), on September 29, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.